Atlas market file · Etf · United States
First Trust Germany AlphaDEX FundFGM
- Last close
- 63.7005
- Change
- -0.36%
- 96-bar range
- 57.45 – 68.85
- As of
- 6 Aug 2026
First Trust Germany AlphaDEX Fund is an exchange-traded fund listed as FGM on NASDAQ. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
- Identity
- Nasdaq Trader
- Chart rail
- TradingView
- File state
- Public profile
Static Daily candlestick snapshot from the approved cache, drawn on a labelled price axis: green bodies closed up, red closed down, wicks span each bar's high-to-low range. The live TradingView link stays available; the public profile never embeds a widget that can render the wrong symbol.
▮ up candle ▮ down candle
Weekly outlook: the last 104 weekly closes (+66.02% over the window).
Source rail: Yahoo Finance chart API (FGM). This dated snapshot is the crawlable Atlas reference.
Live market viewTradingView · provider feed Open view ->
Open the attributed TradingView market view for FGM. The dated Atlas snapshot above remains the crawlable reference; exchange data in this panel may be live or delayed as labelled by TradingView.
FGM public profile
Exchange-traded fund. First Trust Germany AlphaDEX Fund is connected to current market context, cited company sources and its retained research file.
First Trust Germany AlphaDEX Fund trades as FGM on NASDAQ. First Trust Germany AlphaDEX Fund (FGM) has a latest verified close of 63.7005, down 0.36%, dated 6 Aug 2026.
Open the chart, inspect attributed company evidence and continue into the fuller research file without losing this market context. FGM stays in the main symbols index until Atlas has enough listing or name evidence for a narrower browse group.
What changed for First Trust Germany AlphaDEX Fund today
The First Trust Germany AlphaDEX Fund (FGM) is an ETF that promises to deliver “alpha” from German equities, but the fund’s real product is a fee and a rules-based index that does most of the work. The issuer sells a story of active German equity selection, yet the fund’s holdings are mechanically screened and reconstituted quarterly, and the fund trades on Nasdaq like any plain-vanilla tracker. The tension isn’t in the stocks; it’s in the distance between the marketing and the mechanism. The fund’s expense ratio is 0.60%, a figure that compounds quietly while investors focus on DAX headlines. The fund’s mandate is to track the Defined Germany AlphaDEX Index, a quant-driven basket that reweights German mid- and small-caps based on growth and value factors. The index is reconstituted and rebalanced quarterly, and the fund is designed to reflect those changes in real time. The issuer’s pitch leans on “alpha,” but the fund’s structure is closer to a systematic screen than a stock-picker’s dream.
FGM’s holdings are dominated by mid- and small-cap German companies that most retail investors would struggle to name, let alone own. The fund’s top concentrations are typically in industrial machinery, chemicals, and consumer goods-sectors that are structurally sensitive to euro-area demand and global trade winds. The fund’s liquidity is provided by Nasdaq market makers, which quote tight spreads during German trading hours. The fund’s AUM and trading volumes are modest relative to broad European ETFs, but the wrapper is liquid enough to avoid the sort of creeping illiquidity that can haunt niche quant funds. The fund’s expense ratio sits at 0.60%, a figure that is high for a passively tracked index but in line with other smart-beta and quant-driven ETFs. The fund’s tracking method is fully transparent: it replicates the Defined Germany AlphaDEX Index, a rules-based index built by Defined Asset Solutions. The index screens German equities for growth and value factors, ranks them, and assigns weights accordingly. The fund then mirrors that index, minus the fee. The issuer’s marketing emphasizes “alpha,” but the fund’s returns are ultimately a function of the index’s design, the fee, and the euro’s mood.
The fund’s SEC filings confirm the mechanics but reveal no surprises: the fund is a pass-through vehicle for an index that is reconstituted and rebalanced quarterly. The fund’s prospectus and N-PORT filings disclose the index methodology, the fee schedule, and the list of authorised participants, but they do not disclose the fund’s holdings on a real-time basis-only the index’s holdings are published daily. The fund’s liquidity is supported by a small circle of market makers, and the fund’s spreads are tight during European trading hours but can widen during US market stress. The fund’s AUM is not disclosed in the filings, and the issuer’s marketing materials do not provide a figure; the fund’s size is therefore an unknown factor in assessing its market impact.
The fund’s chart route is available on Nasdaq, where traders can watch its daily price action alongside its peers. The fund’s price is driven by the Defined Germany AlphaDEX Index, which is in turn driven by the performance of German mid- and small-cap equities. The fund’s tracking difference versus the index is expected to be within a narrow band, but the fee ensures that the fund’s returns will lag the index by roughly the expense ratio, compounded. The fund’s liquidity is adequate for most retail and institutional flows, but large block trades may move the index slightly due to the fund’s size and the thinness of some of its holdings. The fund’s tracking method is fully rules-based, and the index’s methodology is published, so the fund’s behaviour is predictable in all but the most stressed market conditions.
The fund’s current trading level and chart context can be viewed on Nasdaq, where the fund’s price is quoted alongside its peers and the DAX. The fund’s price is not a forecast of German equity direction; it is a reflection of the index’s rules, the fee, and the market’s willingness to hold the underlying basket. The fund’s structure is transparent, but its returns are ultimately a function of the index’s design, the fee, and the euro’s mood. The fund’s appeal is niche: it is for investors who want German exposure with a quant twist, but who also accept that the twist comes with a fee that never sleeps. The fund’s risks and catalysts are therefore tied to the index’s composition, the fee’s drag, and the liquidity of the underlying holdings.
Sources & evidence · 3 links
This is the public answer layer. The full Atlas report adds the complete Market Wit archive, risk rail, catalyst map, final editor synthesis, PDF/CSV export, email delivery and saved history.
FGM technical readout
Directional bias down. Wilder ADX and ATR computed from Atlas approved daily OHLC through 2026-07-28. Indicators are descriptive statistics, not investment advice.
Open an Atlas research path on FGM
FreedomCore Atlas can expand this public profile into source-led research files with holdings and concentration, index methodology, exposure and overlap, fees and tracking difference, and liquidity context. Each path keeps the underlying public sources visible.
Open Atlas workstation ->Keep FGM research in your Atlas archive
Free Atlas includes the public profile and one owned welcome research artifact after account setup. Atlas Pro adds up to 25 custom research runs a day, a 500-symbol watchlist, saved report versions, and eligible PDF, CSV, and email artifacts. Evidence holds still apply and never become an unverified download. £12/month founding price, locked for life. Research only; not investment advice.
Checking Atlas access...
FGM FAQ
What is First Trust Germany AlphaDEX Fund (FGM)?First Trust Germany AlphaDEX Fund (FGM) has a latest verified close of 63.7005, down 0.36%, dated 6 Aug 2026. Use this page to check the price chart, company context,...
First Trust Germany AlphaDEX Fund (FGM) has a latest verified close of 63.7005, down 0.36%, dated 6 Aug 2026. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
What does Atlas show for FGM?First Trust Germany AlphaDEX Fund (FGM) has a latest verified close of 63.7005, down 0.36%, dated 6 Aug 2026. It brings the latest available chart, company context,...
First Trust Germany AlphaDEX Fund (FGM) has a latest verified close of 63.7005, down 0.36%, dated 6 Aug 2026. It brings the latest available chart, company context, cited sources, risks and the route into the full Atlas research file together. FGM stays in the main symbols index until Atlas has enough listing or name evidence for a narrower browse group.
How often is the FGM page updated?The FGM public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the...
The FGM public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the freshness of the current market snapshot.
Which sources does Atlas use for FGM?The FGM file starts with Nasdaq Trader and TradingView NASDAQ:FGM. The page separates verified market context from company evidence and shows open evidence gaps instead...
The FGM file starts with Nasdaq Trader and TradingView NASDAQ:FGM. The page separates verified market context from company evidence and shows open evidence gaps instead of filling them with assumptions.
Can Atlas run a full research brief on FGM?Yes. The workstation can open FGM, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Yes. The workstation can open FGM, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Is this FGM page investment advice?No. The FGM page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise...
No. The FGM page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise of returns.
Methodology
This profile is generated daily from public sources including SEC EDGAR (US-listed companies), NASDAQ Trader files, exchange listings, public macro/central-bank releases, CoinGecko crypto market files where relevant, and the TradingView global symbol catalog. Multi-model AI may assist drafting and review where configured, but sources remain the evidence rail; the chart is an Atlas static OHLC rail with a live TradingView link when verified bars are available; otherwise the page keeps the verified TradingView route as an explicit fallback.
Research only. Not investment advice. No brokerage execution. No guaranteed returns are promised or implied. FreedomCore does not provide personalised investment advice. Always consult a regulated financial advisor before making investment decisions.
Profile last updated: 2026-08-07. Browse FreedomCore Atlas research notes →
FGM
Etf · evidence first